Product Development

<div class="articleContainer"><div class="articleWrapper"><div class="articleContent"><h1 class="text title">Pfizer, BioNTech first to test COVID-19 vaccine candidate on two continents</h1><h2 class="title-bottom webtitle">BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.</h2><div class="byline">Steve Usdin, Washington Editor</div><div class="date"></div></div></div></div>

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

BioNTech SE

Pfizer Inc.

The announcement Tuesday that healthy volunteers in the U.S. have received a candidate RNA vaccine from Pfizer and BioNTech marks the first COVID-19 vaccin...

cov19count

Pfizer, BioNTech first to test COVID-19 vaccine candidate on two continents

BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.